Released: ·Last reviewed: ·Methodology v4.1
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.
Pharmacy-verification methodology
How we verify the pharmacies behind telehealth GLP-1 and peptide programs.
Verification steps
We confirm the pharmacy is named, check its state license (503A) or FDA registration (503B), verify the prescribing clinician is named, and confirm disclosed concentration and formulation. Unnamed pharmacy equals a failed check.
What we record
Pharmacy name, 503A/503B status, license jurisdictions, FDA registration where applicable, provider relationships, verification URL and date.
How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.